Literature DB >> 11017935

Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study.

M Assumma1, F Signore, L Pacifico, N Rossi, J F Osborn, C Chiesa.   

Abstract

BACKGROUND: The reported sensitivities and specificities of procalcitonin (PCT) concentrations for the diagnosis of neonatal infection vary widely. A postnatal increase of PCT has been observed in healthy term newborns with a peak at approximately 24 h of age, and many questions remain regarding maternal and perinatal factors that may influence the normal PCT kinetics during the immediate postnatal period.
METHODS: We prospectively investigated the association between the serum PCT values obtained from 121 mothers at delivery and serum PCT in their healthy, term offspring at birth as well as at 24 and 48 h of age. We also analyzed whether obstetric and perinatal factors would alter maternal and neonatal PCT response.
RESULTS: PCT concentrations in the babies at birth were significantly higher than in the mothers (P <0.0001), with even larger differences at 24 and 48 h of age. None of the variables identified from maternal and perinatal histories had a significant effect on maternal PCT response. In the healthy neonate, the variables that significantly affected the concentration of PCT at birth were the mothers' PCT (P <0.01), maternal group B streptococcus colonization (P <0.05), and rupture of membranes >/=18 h (P <0.01). The coefficient of linear correlation between the mother's PCT concentration and that of the baby at birth was 0. 32 (P <0.01). The only variable that significantly altered the PCT concentration at both 24 (P <0.01) and 48 (P <0.01) h of age was rupture of membranes >/=18 h. Nonetheless, the PCT response observed during the 48-h period after birth among healthy babies born to mothers with risk factors for infection was well below that reported previously among age-matched neonates with sepsis.
CONCLUSIONS: The postnatal increase of PCT observed in the healthy neonate with peak values at 24 h of age most likely represents endogenous synthesis. In estimating the sensitivities and specificities of PCT for diagnosis of sepsis throughout the initial 48 h of life, it is important to consider the normal PCT kinetics and the pattern(s) of PCT response in the healthy neonate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017935

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

1.  Value of monitoring serum procalcitonin in neonates at risk of infection.

Authors:  M M Koskenvuo; K Irjala; A Kinnala; O Ruuskanen; P Kero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-16       Impact factor: 3.267

Review 2.  Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.

Authors:  Evridiki K Vouloumanou; Eleni Plessa; Drosos E Karageorgopoulos; Elpis Mantadakis; Matthew E Falagas
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440

3.  Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram.

Authors:  D Turner; C Hammerman; B Rudensky; Y Schlesinger; C Goia; M S Schimmel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03-17       Impact factor: 5.747

Review 4.  Umbilical blood biomarkers for predicting early-onset neonatal sepsis.

Authors:  Ying Fan; Jia-Lin Yu
Journal:  World J Pediatr       Date:  2012-05-10       Impact factor: 2.764

5.  Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.

Authors:  Martin Stocker; Wim C J Hop; Annemarie M C van Rossum
Journal:  BMC Pediatr       Date:  2010-12-08       Impact factor: 2.125

6.  Laboratory aid to the diagnosis and therapy of infection in the neonate.

Authors:  Gaetano Chirico; Cristina Loda
Journal:  Pediatr Rep       Date:  2011-02-24

7.  Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission.

Authors:  José B López Sastre; David Pérez Solís; Vicente Roqués Serradilla; Belén Fernández Colomer; Gil D Coto Cotallo
Journal:  BMC Pediatr       Date:  2007-02-26       Impact factor: 2.125

8.  Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.

Authors:  Helena Brodska; Tomas Drabek; Karin Malickova; Antonin Kazda; Antonin Vitek; Tomas Zima; Marketa Markova
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

9.  A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting.

Authors:  Kamalpreet Kaur; Rajiv Mahajan; Aparna Tanwar
Journal:  Int J Appl Basic Med Res       Date:  2013-07

Review 10.  Neonatal sepsis: an old problem with new insights.

Authors:  Birju A Shah; James F Padbury
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.